Skip to Content

Ashish Life Sciences Boisar, India, 2023

GMP Audit Report

Company
Ashish Life Sciences Boisar

Product(s)
Albendazole boli, Levamisole boli

Country
India

Audit Year
2023


0.00 € 0.00 €
0.00 €